Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: A rebuttal

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 6, 2011, Pages 1266-1267

  Agusti Cobos E ^a   Tenorio Laranga, J ^b  

^a Hospital of Figueres   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTICOAGULANT AGENT; CITRIC ACID; EDETIC ACID; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; SEPRASE; UNCLASSIFIED DRUG; Z PROLYL PROLINAL;

ANTICOAGULATION; BLOOD SAMPLING; BODY FLUID; CEREBROSPINAL FLUID; CIRCULATION; DEPRESSION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MODIFICATION; FIBRINOLYSIS; HUMAN; INFORMED CONSENT; LETTER; MAMMAL; MANIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; SCHIZOPHRENIA;

ALPHA-2-ANTIPLASMIN; FIBRINOLYSIS; HUMANS;

EID: 79958043816     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04294.x     Document Type: Letter

References (10)

1. 2 -antiplasmin. J Thromb Haemost 2011; 9: 987-96.
2. Tenorio-Laranga J, Coret-Ferrer F, Casanova-Estruch B, Burgal M, García-Horsman JA. Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis. J Neuroinflammation 2010; 7: 23.
3. Breen G, Harwood AJ, Gregory K, Sinclair M, Collier D, St Clair D, Williams RS. Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord 2004; 6: 156-61.
4. Polgar L. Prolyl oligopeptidases. Methods Enzymol 1994; 244: 188-200.
5. Tenorio-Laranga J, Männistö PT, García-Horsman JA. Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides. CNS Neurol Disord Drug Targets 2011; 10: 319-326.
6. Tenorio-Laranga J, Venäläinen JI, Männistö PT, García-Horsman JA. Characterization of membrane-bound prolyl endopeptidase from brain. FEBS J 2008; 275: 4415-27.
7. Maes M, Goossens F, Scharpe S, Meltzer HY, D'Hondt P, Cosyns P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol Psychiatry 1994; 35: 545-52.
8. Maes M, Libbrecht I, van Hunsel F, Lin AH, Bonaccorso S, Goossens F, De Meester I, De Clerck L, Biondi M, Scharpe S, Janca A. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia. Psychol Med 1998; 28: 957-65.
9. Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, Meltzer HY. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 1995; 58: 217-25.
10. Collins PJ, McMahon G, O'Brien P, O'Connor B. Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol 2004; 36: 2320-33.